SCHEMBL23928885

SCHEMBL23928885

O=C1CC2(CN(C(=O)O)C2)Oc2ccc(Cl)cc21

nearest known ligand 0.49

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
ACACB O00763 1/20 0.49
HDAC3 O15379 11/20 0.48
HDAC4 P56524 11/20 0.48
HDAC1 Q13547 11/20 0.48
HDAC7 Q8WUI4 11/20 0.48
HDAC2 Q92769 11/20 0.48
HDAC10 Q969S8 11/20 0.48
HDAC11 Q96DB2 11/20 0.48
HDAC8 Q9BY41 11/20 0.48
HDAC6 Q9UBN7 11/20 0.48
HDAC9 Q9UKV0 11/20 0.48
HDAC5 Q9UQL6 11/20 0.48
HSD11B1 P28845 1/20 0.44
KMT2A Q03164 1/20 0.44
KDM4E B2RXH2 2/20 0.43
HTT P42858 1/20 0.42
ATM Q13315 1/20 0.42
CHRNA7 P36544 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL16291672 0.84 HDAC3 (0.51) HDAC3HDAC4HDAC1HDAC7HDAC2
SCHEMBL23928855 0.82 HDAC3 (0.48) ACACBHDAC3HDAC4HDAC1HDAC7
SCHEMBL30587446 0.82 HDAC3 (0.48) ACACBHDAC3HDAC4HDAC1HDAC7
SCHEMBL23928896 0.81 SIGMAR1 (0.53) HDAC3HDAC4HDAC1HDAC7HDAC2
SCHEMBL620381 0.77 KDM4E (0.64) ACACBHDAC3HDAC4HDAC1HDAC7
SCHEMBL22174121 0.77 ACACB (0.55) ACACBHDAC3HDAC4HDAC1HDAC7
SCHEMBL23928878 0.76 CHRNA7 (0.54) HDAC3HDAC4HDAC1HDAC7HDAC2
SCHEMBL4351287 0.76 KDM4E (0.69) ACACBHDAC3HDAC4HDAC1HDAC7
SCHEMBL23957151 0.76 HDAC3 (0.55) ACACBHDAC3HDAC4HDAC1HDAC7
Hydrochloric Acid SCHEMBL31020827 0.75 HDAC3 (0.54) ACACBHDAC3HDAC4HDAC1HDAC7

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3820869-B1 SPIROCHROMANE DERIVATIVES RICHTER GEDEON NYRT (HU) 2023-08-30 EP disclosed
US-20210330650-A1 SPIROCHROMANE DERIVATIVES RICHTER GEDEON NYRT. (HU) 2021-10-28 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20210330650-A1 SPIROCHROMANE DERIVATIVES CHRNA7, CHRM3, ADRB3 ACACB 3164/4885HDAC3 120/4885HDAC4 914/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.